API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
EU WC
Listed Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208043
https://www.prnewswire.com/news-releases/currax-pharmaceuticals-announces-the-appointment-of-ed-cinca-to-senior-vice-president-global-marketing-and-strategic-alliance-management-301408090.html
https://www.statnews.com/2020/02/24/alkermes-sued-death-overdosed-vivitrol/
https://endpts.com/fda-slaps-down-alkermes-for-misleading-vivitrol-ads-dont-forget-vulnerability-to-opioid-overdose/
https://www.patentdocs.org/2019/08/nalproprion-pharmaceuticals-inc-v-actavis-laboratories-fl-inc-fed-cir-2019.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-14-2018-1542217134.pdf
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-embeda-22321-morphine-sulfate-and-naltrexone-hydrochloride-extended-release-capsules-1538195912.pdf
https://www.pharmacompass.com/pdf/news/Enforcement-Report-Week-of-August-22-2018-1534903909.pdf
https://www.in-pharmatechnologist.com/Article/2018/07/11/Elite-Pharma-Eyes-on-Troxyca-but-Pfizer-blocking-generic-release
https://endpts.com/with-debt-looming-browbeaten-diet-pill-maker-orexigen-goes-bankrupt/
http://www.nwaonline.com/news/2018/feb/26/fda-to-boost-drug-therapy-for-addicts-2/?news-national
https://www.globenewswire.com/news-release/2018/12/19/1669738/0/en/Nalpropion-Pharmaceuticals-Inc-Expands-Agreement-with-iNova-Pharmaceuticals-for-Exclusive-Commercialization-Rights-for-Contrave-naltrexone-HCl-bupropion-HCl-extended-release-to-inc.html
https://www.cnbc.com/2018/01/08/alkermes-ceo-our-opioid-addiction-treatment-has-best-days-ahead.html
https://www.biospace.com/article/unique-alkermes-allegedly-fired-3-female-employees-who-raised-concerns-of-bias/
https://endpts.com/alkermes-touts-equal-efficacy-of-monthly-vivitrol-against-daily-suboxone/
https://www.prnewswire.com/news-releases/orexigen-therapeutics-announces-commercialization-and-distributorship-agreement-with-merck-kgaa-darmstadt-germany-for-contrave-in-latin-america-300554337.html
http://www.fiercepharma.com/legal/alkermes-balks-at-u-s-senator-harris-probe-into-vivitrol-marketing
https://www.statnews.com/2017/10/18/opioid-addiction-vivitrol-suboxone/?_hsenc=p2ANqtz-9M0CpP80HRyoUrIxu1t8Wu-_jj91GnGchS3jLLYDnESLoCbJRqLcl_NB8iCy5sl_kLGcVcsIlhRmUqi7m-JhwgoZFowA&_hsmi=57535032
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207905
http://www.prnewswire.com/news-releases/orexigen-therapeutics-announces-expansion-of-distributorship-agreement-with-biologix-fzco-for-contrave-naltrexone-hcl--bupropion-hcl-extended-release-to-egypt-300494141.html
http://raps.org/Regulatory-Focus/News/2017/05/24/27644/FDA-Cracks-Down-on-TV-Ad-for-Prescription-Weight-Loss-Drug/?utm_source=Email&utm_medium=Informz&utm_campaign=Informz-Emails
http://www.fiercepharma.com/manufacturing/alkermes-adding-90-jobs-at-ohio-plant
http://www.prnewswire.com/news-releases/orexigen-therapeutics-announces-spanish-launch-of-mysimba-naltrexone-hcl--bupropion-hcl-prolonged-release-in-partnership-with-laboratorios-farmaceuticos-rovi-sa-300396318.html
https://globenewswire.com/news-release/2016/12/22/901329/0/en/Elite-Provides-Update-on-SequestOx-New-Drug-Application.html
http://www.prnewswire.com/news-releases/orexigen-therapeutics-announces-commercialization-and-distributorship-agreement-with-consilient-health-ltd-for-mysimba-naltrexone-hcl--bupropion-hcl-prolonged-release-in-the-uk-and-ireland-300374839.html
http://www.bostonglobe.com/business/2016/10/20/alkermes-stock-climbs-positive-test-results-for-antidepressant/g4bWeMg3SEwogvtSor63UO/story.html?
http://www.biospace.com/News/pfizer-release-fda-approves-troxyca-er-oxycodone/429997/source=MoreNews
https://www.pharmacompass.com/pdf/news/fda-approves-pfizers-abuse-deterrent-troxyca-er-for-management-of-severe-pain-1472292585.pdf
http://www.pharmatimes.com/news/pfizers_abuse-resistant_opioid_nears_us_market_1037297
http://www.prnewswire.com/news-releases/orexigen-announces-south-korean-approval-of-contrave-naltrexone-hci-and-bupropion-hci-extended-release-monotherapy-for-weight-management-in-overweight-or-obese-adult-patients-300260615.html
http://www.pharma-excipients.ch/2016/03/30/compatibility-of-different-apis-in-syrspend-sf-ph4-oral-suspensions/
http://www.prnewswire.com/news-releases/orexigen-announces-submission-of-contrave-new-drug-application-in-south-korea-300152333.html
http://www.prnewswire.com/news-releases/orexigen-raises-60-million-in-sale-of-common-stock-to-baupost-300140826.html
http://www.biospace.com/News/orexigen-and-takeda-file-lawsuit-against-actavis/380188/source=MoreNews
http://www.fiercepharmaasia.com/story/contrave-trial-tussle-brews-between-takeda-orexigen-cleveland-clinic-scene/2015-05-13
http://www.pfizer.com/system/files/presentation/Q1_2015_PFE_Earnings_Press_Release_foijsdflskd.pdf?linkId=13824525
http://www.fiercepharma.com/story/eisai-gets-ema-nod-lenvima-just-weeks-after-fda-approval/2015-03-27
http://www.medpagetoday.com/Endocrinology/Diabetes/50672?xid=nl_mpt_DHE_2015-03-27&eun=g655567d0r&userid=655567&mu_id=5789356
http://www.pharmatimes.com/Article/15-03-26/Europe_approves_Orexigen_s_weight-loss_pill_Mysimba.aspx
http://www.medpagetoday.com/Psychiatry/Addictions/50541
http://www.wsj.com/articles/weight-loss-drugs-seek-acceptance-from-patients-and-physicians-1426526252
http://blogs.wsj.com/pharmalot/2015/03/09/what-should-fda-do-about-the-orexigen-data-disclosure-take-our-poll/
http://www.fiercepharmamarketing.com/story/surprise-obesity-med-contrave-might-help-cv-outcomes-too-bad-orexigen-blabb/2015-03-04